PMCC Leveraged Lease (Benefit) Charge

Comparisons of Altria's nine-month reported diluted EPS were also impacted by benefits and charges related to the tax treatment of certain leveraged lease transactions entered into by PMCC (referred to by the Internal Revenue Service (IRS) as lease-in/lease-out (LILO) and sale-in/lease-out (SILO) transactions).

For the first nine months of 2012, Altria recorded a net earnings benefit of $68 million primarily due to lower than estimated interest expense on tax underpayments as a result of the previously announced closing agreement with the IRS related to PMCC's LILO and SILO transactions. This 2012 nine-month EPS benefit is shown in Table 2 and Schedule 7. The net benefit was recorded as a decrease of $75 million to the provision for income taxes and is reflected in Schedule 3, “Provision for income taxes.” This benefit was partially offset by a reduction to cumulative lease earnings of $7 million against the financial services segment's net revenues as shown in Schedule 4.

For the first nine months of 2011, Altria's reported diluted EPS was impacted by a charge of $627 million related to PMCC's LILO and SILO transactions. The EPS impact of the charge is shown in Table 2 and Schedule 7. The charge was recorded as a reduction to cumulative lease earnings of $490 million against the financial services segment's net revenues, which is reflected in Schedule 4, and a net increase of $137 million to the provision for income taxes as reflected in Schedule 3, “Provision for income taxes.”

Tobacco and Health Judgments

Comparisons of Altria's nine-month reported diluted EPS were also impacted by charges related to tobacco and health judgments. For the first nine months of 2012, PM USA incurred pre-tax charges of $4 million for tobacco and health judgments. For the first nine months of 2011, PM USA incurred pre-tax charges of $36 million for tobacco and health judgments as well as related interest costs of $5 million. For the third quarter of 2012, PM USA incurred pre-tax charges of $3 million for tobacco and health judgments. These charges, excluding interest costs, are reflected in Schedules 2 and 4, and the EPS impact of these charges, including interest costs, is reflected in Table 2, and in Schedules 6 and 7. The interest costs related to the tobacco and health judgments are reflected in Schedule 3, “Interest and other debt expense, net.”

If you liked this article you might like

STMicroelectronics, Intercept Pharmaceuticals: 'Mad Money' Lightning Round

Watch Out For the Dominoes That Fall: Cramer's 'Mad Money' Recap (Wed 9/20/17)

These Stocks Pay You to Own Them

From the Marlboro Man to Vaping, Here Are the Events that Shaped Big Tobacco

Tobacco Stocks Mixed as FDA Launches Campaign to Keep Kids Away From E-Cigarettes